Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	RELN FN1 MUC17 VCAN COL14A1 MUC3A MUC5AC	1.66e-04	188	123	7	GO:0005201
GeneOntologyMolecularFunction	inositol hexakisphosphate binding	ITPR3 SNAP91	2.24e-04	4	123	2	GO:0000822
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A	2.24e-04	4	123	2	GO:0030197
GeneOntologyMolecularFunction	cadherin binding	CALD1 ANK3 COBLL1 MYO1B SHTN1 PDLIM5 PTPRJ TJP2 HCFC1	2.54e-04	339	123	9	GO:0045296
GeneOntologyMolecularFunction	cytoskeletal protein binding	TPR SYNPO2 CALD1 ANK3 GIT1 COBLL1 MYO1B NUP62 NEDD1 SHTN1 PDLIM5 MAP3K1 SPAG5 HNRNPU ALMS1 SVIL MRTFA	4.11e-04	1099	123	17	GO:0008092
GeneOntologyMolecularFunction	structural constituent of nuclear pore	TPR NUP62 POM121B	4.75e-04	25	123	3	GO:0017056
GeneOntologyMolecularFunction	alpha-actinin binding	SYNPO2 PDLIM5 ALMS1	9.04e-04	31	123	3	GO:0051393
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate binding	MYO1B FCHO2 WDR45 SNAP91 SVIL	9.19e-04	121	123	5	GO:1902936
GeneOntologyCellularComponent	Golgi lumen	MUC19 MUC16 MUC12 MUC17 VCAN MUC3A MUC5AC	4.15e-06	109	125	7	GO:0005796
GeneOntologyCellularComponent	nuclear protein-containing complex	TPR TTF2 RANBP2 MAFK ICE2 KDM3B U2AF2 POU2F1 NUP62 ADAR HNRNPU BAP1 PHC3 KMT2D AAAS BAZ2A TET1 AGFG1 TAF4 MGA POM121B HCFC1	2.09e-05	1377	125	22	GO:0140513
GeneOntologyCellularComponent	nuclear pore	TPR RANBP2 NUP62 AAAS AGFG1 POM121B	3.23e-05	101	125	6	GO:0005643
GeneOntologyCellularComponent	mitotic spindle	TPR GIT1 NUP62 SPAG5 HNRNPU AAAS PHLPP2	2.10e-04	201	125	7	GO:0072686
GeneOntologyCellularComponent	spindle pole	GIT1 NUP62 NEDD1 SPAG5 HNRNPU AAAS ALMS1	2.36e-04	205	125	7	GO:0000922
GeneOntologyCellularComponent	costamere	ANK3 SVIL AHNAK2	2.96e-04	22	125	3	GO:0043034
GeneOntologyCellularComponent	presynapse	TNIK DMXL2 NPY5R GIT1 NCSTN NR4A1 FCHO2 PNISR PDLIM5 ITPR3 SNAP91 ITSN2 BSN MCTP2	8.49e-04	886	125	14	GO:0098793
GeneOntologyCellularComponent	apical part of cell	TNIK FN1 MYO1B NEDD1 MFRP ITPR3 SLC15A1 MUC17 PTPRQ OSMR PDZD2	8.62e-04	592	125	11	GO:0045177
GeneOntologyCellularComponent	MLL1 complex	TAF4 MGA HCFC1	9.12e-04	32	125	3	GO:0071339
GeneOntologyCellularComponent	symbiont cell surface	C4A C4B	9.70e-04	8	125	2	GO:0106139
GeneOntologyCellularComponent	MLL1/2 complex	TAF4 MGA HCFC1	9.99e-04	33	125	3	GO:0044665
GeneOntologyCellularComponent	histone methyltransferase complex	KMT2D TAF4 MGA HCFC1	1.07e-03	75	125	4	GO:0035097
GeneOntologyCellularComponent	other organism part	C4A C4B	1.24e-03	9	125	2	GO:0044217
GeneOntologyCellularComponent	myofibril	SYNPO2 CALD1 ANK3 MYOM3 PDLIM5 SVIL AHNAK2	1.29e-03	273	125	7	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	SYNPO2 CALD1 ANK3 MYOM3 PDLIM5 SVIL AHNAK2	1.82e-03	290	125	7	GO:0043292
GeneOntologyCellularComponent	NSL complex	PHF20L1 HCFC1	1.88e-03	11	125	2	GO:0044545
GeneOntologyCellularComponent	spindle	TPR GIT1 NUP62 NEDD1 SPAG5 HNRNPU AAAS ALMS1 PHLPP2	2.12e-03	471	125	9	GO:0005819
Domain	SEA	MUC16 MUC12 TMPRSS11F MUC17 MUC3A	3.35e-07	23	122	5	PS50024
Domain	SEA_dom	MUC16 MUC12 TMPRSS11F MUC17 MUC3A	3.35e-07	23	122	5	IPR000082
Domain	SEA	MUC16 TMPRSS11F MUC17 MUC3A	1.65e-06	14	122	4	SM00200
Domain	SEA	MUC16 MUC12 TMPRSS11F MUC17	1.16e-05	22	122	4	PF01390
Domain	-	MUC16 TMPRSS11F MUC17	1.17e-04	15	122	3	3.30.70.960
Domain	FOXP-CC	FOXP4 FOXP3	2.52e-04	4	122	2	PF16159
Domain	FOXP-CC	FOXP4 FOXP3	2.52e-04	4	122	2	IPR032354
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2	2.52e-04	4	122	2	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2	2.52e-04	4	122	2	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2	2.52e-04	4	122	2	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2	2.52e-04	4	122	2	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2	2.52e-04	4	122	2	IPR015753
Domain	Anaphylatoxin_comp_syst	C4A C4B	4.18e-04	5	122	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	4.18e-04	5	122	2	IPR001840
Domain	ANATO	C4A C4B	8.70e-04	7	122	2	SM00104
Domain	ANAPHYLATOXIN_2	C4A C4B	8.70e-04	7	122	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	8.70e-04	7	122	2	PS01177
Domain	ANATO	C4A C4B	8.70e-04	7	122	2	PF01821
Domain	Anaphylatoxin/fibulin	C4A C4B	8.70e-04	7	122	2	IPR000020
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	1.15e-03	8	122	2	IPR019565
Domain	Thiol-ester_cl	C4A C4B	1.15e-03	8	122	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	1.15e-03	8	122	2	IPR019742
Domain	FN3	FN1 MYOM3 PTPRJ COL14A1 OSMR HCFC1	1.36e-03	185	122	6	SM00060
Domain	A2M	C4A C4B	1.84e-03	10	122	2	PF00207
Domain	A2M_N_2	C4A C4B	1.84e-03	10	122	2	IPR011625
Domain	A2M_comp	C4A C4B	1.84e-03	10	122	2	IPR011626
Domain	A2M_recep	C4A C4B	1.84e-03	10	122	2	PF07677
Domain	A2M_comp	C4A C4B	1.84e-03	10	122	2	PF07678
Domain	A2M_N	C4A C4B	1.84e-03	10	122	2	PF01835
Domain	A2M_N	C4A C4B	1.84e-03	10	122	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B	1.84e-03	10	122	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B	1.84e-03	10	122	2	PS00477
Domain	A2M_N_2	C4A C4B	1.84e-03	10	122	2	PF07703
Domain	Macroglobln_a2	C4A C4B	1.84e-03	10	122	2	IPR001599
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC12 MUC17 MUC3A MUC5AC	3.70e-08	16	89	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC12 MUC17 MUC3A MUC5AC	5.22e-08	17	89	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC12 MUC17 MUC3A MUC5AC	2.75e-07	23	89	5	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC12 MUC17 MUC3A MUC5AC	5.31e-07	26	89	5	M27483
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	TPR RANBP2 NUP62 PHC3 AAAS POM121B	1.66e-06	58	89	6	MM15149
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	TPR RANBP2 NUP62 PHC3 AAAS POM121B	3.27e-06	65	89	6	MM15147
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	TPR RANBP2 NUP62 AAAS POM121B	4.95e-06	40	89	5	MM14945
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	TPR RANBP2 NUP62 AAAS POM121B	5.61e-06	41	89	5	MM15200
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	TPR RANBP2 NUP62 AAAS POM121B	6.34e-06	42	89	5	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	TPR RANBP2 NUP62 AAAS POM121B	7.13e-06	43	89	5	MM14609
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC17 MUC5AC	8.18e-06	21	89	4	MM15706
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	TPR RANBP2 NUP62 PHC3 AAAS	1.11e-05	47	89	5	M27395
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	TPR RANBP2 NUP62 AAAS POM121B	1.11e-05	47	89	5	MM14939
Pathway	REACTOME_GENE_SILENCING_BY_RNA	TPR RANBP2 NUP62 AAAS POM121B	1.37e-05	49	89	5	MM14837
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	TPR RANBP2 NUP62 PHC3 AAAS POM121B	1.46e-05	84	89	6	MM14929
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	TPR RANBP2 NUP62 AAAS POM121B	1.52e-05	50	89	5	MM14610
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	TPR RANBP2 NUP62 AAAS POM121B	1.67e-05	51	89	5	MM15151
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	TPR RANBP2 U2AF2 NUP62 AAAS POM121B	1.67e-05	86	89	6	MM15413
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	TPR RANBP2 NUP62 AAAS POM121B	2.43e-05	55	89	5	MM14917
Pathway	REACTOME_SNRNP_ASSEMBLY	TPR RANBP2 NUP62 AAAS POM121B	3.15e-05	58	89	5	MM14736
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC12 MUC17 MUC3A MUC5AC	4.36e-05	62	89	5	M546
Pathway	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	TPR RANBP2 NUP62 AAAS	4.66e-05	32	89	4	M29579
Pathway	REACTOME_ALK_MUTANTS_BIND_TKIS	FN1 STRN ALK	5.14e-05	12	89	3	M42522
Pathway	REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	TPR RANBP2 NUP62 AAAS	5.28e-05	33	89	4	M27016
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	TPR RANBP2 ICE2 U2AF2 POU2F1 NUP62 NR4A1 PRKAG3 PHC3 KMT2D AAAS PHF20L1 ZFHX3 TAF4 MGA POM121B HCFC1 FOXP3	5.80e-05	1022	89	18	MM15436
Pathway	REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	TPR RANBP2 NUP62 AAAS	5.96e-05	34	89	4	M27041
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	TPR RANBP2 NUP62 AAAS	6.69e-05	35	89	4	M27320
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC12 MUC17 MUC3A MUC5AC	6.83e-05	68	89	5	M27303
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	TPR RANBP2 NUP62 AAAS	7.49e-05	36	89	4	M26974
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	TPR RANBP2 NUP62 AAAS	7.49e-05	36	89	4	M27245
Pathway	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	TPR RANBP2 NUP62 AAAS	8.36e-05	37	89	4	M1029
Pathway	REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	TPR RANBP2 NUP62 AAAS	8.36e-05	37	89	4	M27038
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	TPR RANBP2 NUP62 PHC3 AAAS	8.40e-05	71	89	5	M27394
Pathway	REACTOME_SUMOYLATION	TPR RANBP2 NUP62 PHC3 AAAS POM121B MRTFA	9.48e-05	169	89	7	MM14919
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	TPR RANBP2 NUP62 AAAS POM121B	9.59e-05	73	89	5	MM14948
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	TPR RANBP2 NUP62 AAAS	1.03e-04	39	89	4	M27238
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	TPR RANBP2 NUP62 PHC3 AAAS	1.24e-04	77	89	5	M27226
Pathway	REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	TPR RANBP2 NUP62 AAAS	1.26e-04	41	89	4	M29574
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	TPR RANBP2 NUP62 AAAS	1.52e-04	43	89	4	M26975
Pathway	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	TPR RANBP2 NUP62 AAAS	1.66e-04	44	89	4	M109
Pathway	REACTOME_GLUCOSE_METABOLISM	TPR RANBP2 NUP62 AAAS POM121B	1.67e-04	82	89	5	MM15394
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	TPR RANBP2 U2AF2 NUP62 AAAS	1.87e-04	84	89	5	M725
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	TPR RANBP2 NUP62 AAAS	1.98e-04	46	89	4	M27397
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC12 ITPR3 MUC17 MUC3A MUC5AC	2.55e-04	140	89	6	M27484
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC12 MUC17 VCAN MUC3A MUC5AC	2.86e-04	143	89	6	M27275
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	TPR RANBP2 NUP62 AAAS POM121B	2.86e-04	92	89	5	MM14951
Pathway	REACTOME_SIGNALING_BY_ALK_IN_CANCER	TPR RANBP2 FN1 STRN ALK	3.01e-04	93	89	5	M42521
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	TPR RANBP2 NUP62 AAAS	3.43e-04	53	89	4	M27212
Pathway	REACTOME_SNRNP_ASSEMBLY	TPR RANBP2 NUP62 AAAS	3.69e-04	54	89	4	M29594
Pathway	REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS	TPR RANBP2 NUP62 AAAS	5.18e-04	59	89	4	M27606
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC19 MUC16 MUC17 MUC5AC	5.53e-04	60	89	4	MM15636
Pathway	KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119	BAP1 PHC3 HCFC1	5.69e-04	26	89	3	M47923
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC12 MUC17 MUC3A MUC5AC	6.79e-04	111	89	5	M27416
Pathway	REACTOME_MITOTIC_PROPHASE	TPR RANBP2 NUP62 AAAS POM121B	7.66e-04	114	89	5	MM15361
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C4A C4B	8.11e-04	7	89	2	MM14685
Pathway	KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION	C4A C4B	1.08e-03	8	89	2	M47872
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C4A C4B	1.08e-03	8	89	2	M27031
Pathway	REACTOME_ISG15_ANTIVIRAL_MECHANISM	TPR RANBP2 NUP62 AAAS	1.22e-03	74	89	4	M48006
Pathway	REACTOME_SUMOYLATION	TPR RANBP2 NUP62 PHC3 AAAS MRTFA	1.24e-03	189	89	6	M27214
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	TPR RANBP2 MAN2B1 NUP62 AAAS VCAN POM121B	1.62e-03	271	89	7	MM15406
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KMT2D PHF20L1 HCFC1	1.75e-03	38	89	3	MM17073
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	TPR RANBP2 NUP62 AAAS	1.78e-03	82	89	4	M27250
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	TPR RANBP2 U2AF2 NUP62 HNRNPU AAAS POM121B	1.83e-03	277	89	7	MM15414
Pathway	REACTOME_GLUCOSE_METABOLISM	TPR RANBP2 NUP62 AAAS	2.04e-03	85	89	4	M1870
Pathway	BIOCARTA_NPC_PATHWAY	RANBP2 NUP62	2.09e-03	11	89	2	M22033
Pathway	KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION	C4A C4B	2.09e-03	11	89	2	M47874
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B	2.09e-03	11	89	2	MM1430
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KMT2D PHF20L1 HCFC1	2.34e-03	42	89	3	M48018
Pathway	WP_OXIDATIVE_DAMAGE_RESPONSE	MAP3K1 C4A C4B	2.34e-03	42	89	3	MM15945
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	TPR RANBP2 FN1 MUC19 MUC16 U2AF2 NUP62 BAP1 PHC3 AAAS MUC17 VCAN C4A C4B POM121B MUC5AC HCFC1 MRTFA	2.35e-03	1389	89	18	MM15307
Pathway	BIOCARTA_CLASSIC_PATHWAY	C4A C4B	2.50e-03	12	89	2	MM1368
Pathway	REACTOME_HIV_LIFE_CYCLE	TPR RANBP2 NUP62 AAAS TAF4	2.51e-03	149	89	5	M4076
Pathway	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	TPR RANBP2 NUP62 ADAR AAAS	2.66e-03	151	89	5	M550
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B	2.94e-03	13	89	2	M4732
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TNIK TPR TTF2 RANBP2 CALD1 KDM3B MYO1B NUP62 NEDD1 SHTN1 ADAR CIC EMSY PDLIM5 SPAG5 HNRNPU PHC3 FAM193A ALMS1 BAZ2A KIAA1217 AGFG1 PPP6R2 HCFC1 AHNAK2	7.08e-15	934	128	25	33916271
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR TTF2 CALD1 ANK3 KDM3B SHTN1 ADAR EMSY PDLIM5 KMT2D ALMS1 BAZ2A TET1 TJP2 TAF4 MGA SPEN HCFC1 ZMYM4	1.92e-13	549	128	19	38280479
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR RANBP2 RREB1 SHTN1 CIC SPAG5 BAP1 PHC3 KMT2D FAM193A RESF1 ALMS1 TET1 ZFHX3 MGA ZMYM4 MRTFA	3.00e-13	418	128	17	34709266
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TNIK JCAD TTF2 RANBP2 CALD1 GIT1 NUP62 FCHO2 NEDD1 EMSY PDLIM5 SPAG5 STRN ALMS1 PROSER3 KIAA1217 SVIL ITSN2 TJP2 MGA PPP6R2 FHIP1A	7.39e-13	853	128	22	28718761
Pubmed	Interaction network of human early embryonic transcription factors.	RANBP2 POU2F1 RREB1 AHDC1 EMSY FOXP4 KMT2D RESF1 ALMS1 TET1 ZFHX3 TAF4 MGA SPEN ZMYM4	4.02e-12	351	128	15	38297188
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR RANBP2 GIT1 KDM3B POU2F1 RREB1 PNISR CIC EMSY BAP1 PHC3 TBC1D10B KMT2D ABCB9 BAZ2A SVIL TJP2 SPEN ZMYM4 MRTFA	8.78e-12	774	128	20	15302935
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC12 MUC17 MUC3A MUC5AC	3.95e-11	18	128	6	18834073
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TTF2 RANBP2 MAFK U2AF2 NUP62 NR4A1 RREB1 PNISR ADAR AHDC1 CIC EMSY HNRNPU BAP1 ITPR3 PHC3 KMT2D AAAS BAZ2A TAF4 MGA SPEN HCFC1 ZMYM4	5.97e-11	1294	128	24	30804502
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	JCAD SYNPO2 CUX2 ANK3 CIC MAP3K1 C6orf132 PHC3 FAM193A AGFG1 BSN MGA SPEN FHIP1A MRTFA	7.01e-11	430	128	15	35044719
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	RANBP2 CALD1 ICE2 KDM3B NEDD1 AHDC1 EMSY HNRNPU STRN RESF1 TAF4 MGA HCFC1 ZMYM4 AHNAK2	1.09e-10	444	128	15	34795231
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR RANBP2 CALD1 U2AF2 NUP62 RREB1 ADAR CIC EMSY HNRNPU PHC3 SNAP91 BAZ2A AGFG1 TAF4 MGA SPEN ALK HCFC1 ZMYM4	3.50e-10	954	128	20	36373674
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK TPR RANBP2 DMXL2 ANK3 GIT1 SHTN1 EMSY HNRNPU WDR45 STRN SNAP91 KIAA1217 SVIL TAF4 BSN MGA PPP6R2 PLP1	2.73e-09	963	128	19	28671696
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	JCAD CALD1 ANK3 COBLL1 MYO1B SHTN1 PDLIM5 C6orf132 TBC1D10B PTPRJ KIAA1217 SVIL AGFG1 TJP2 HCFC1	2.95e-09	565	128	15	25468996
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	JCAD GIT1 COBLL1 DCP2 KDM3B NUP62 SHTN1 CIC C6orf132 TBC1D10B RESF1 ALMS1 KIAA1217 SVIL TET1 AGFG1 TJP2 AHNAK2	3.03e-09	861	128	18	36931259
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3B POU2F1 CHD9 RREB1 CIC EMSY BAP1 PHC3 PHF20L1 BAZ2A TAF4 MGA SPEN HCFC1 ZMYM4	7.88e-09	608	128	15	36089195
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	RANBP2 MUC19 NUP62 EMSY RESF1 HCFC1 AHNAK2 PDZD2	1.95e-08	123	128	8	26912792
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TTF2 RANBP2 MAFK KDM3B POU2F1 CHD9 RREB1 NEDD1 ADAR AHDC1 CIC EMSY HNRNPU KMT2D RESF1 TAF4 SPEN HCFC1 ZMYM4	2.40e-08	1103	128	19	34189442
Pubmed	Human transcription factor protein interaction networks.	POU2F1 MYO1B R3HDM2 NUP62 RREB1 CIC EMSY BAP1 PHC3 FOXP4 KMT2D RESF1 ALMS1 SVIL SP9 ZFHX3 TAF4 MGA SPEN HCFC1 ZMYM4	6.16e-08	1429	128	21	35140242
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR RELN CALD1 EMSY PDLIM5 HNRNPU ITPR3 KIAA1217 SVIL TJP2 AHNAK2	1.04e-07	360	128	11	33111431
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR TTF2 RANBP2 POU2F1 ADAR CIC EMSY BAP1 FOXP4 KMT2D PHF20L1 MGA SPEN HCFC1 ZMYM4 FOXP3	1.15e-07	857	128	16	25609649
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	EMSY FOXP4 KMT2D RESF1 TAF4 MGA HCFC1 ZMYM4	2.09e-07	167	128	8	20362541
Pubmed	A human MAP kinase interactome.	TPR RANBP2 SYNPO2 ANK3 COBLL1 MUC12 PNISR CIC ITSN2 AGFG1 C4A MGA	2.66e-07	486	128	12	20936779
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	TPR RANBP2 NUP62 AAAS POM121B	2.84e-07	38	128	5	12791264
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	GIT1 MYO1B CIC EMSY STRN RESF1 ALMS1 KIAA1217 AGFG1 BSN PPP6R2 SPEN ZMYM4	2.90e-07	588	128	13	38580884
Pubmed	JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase.	RANBP2 NEDD1 SPAG5 PPP6R2	3.08e-07	16	128	4	26291670
Pubmed	Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.	TPR RANBP2 NUP62 ADAR STRN	3.70e-07	40	128	5	37516964
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TPR TTF2 RANBP2 CALD1 ANK3 ICE2 COBLL1 MYO1B FCHO2 SHTN1 PDLIM5 HNRNPU TBC1D10B HCFC1	3.80e-07	708	128	14	39231216
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TNIK ICE2 KDM3B RREB1 NEDD1 PDLIM5 AAAS FAM193A ALMS1 PROSER3 AGFG1 TJP2 MGA HCFC1	5.74e-07	733	128	14	34672954
Pubmed	Interactome Analysis Reveals a Novel Role for RAD6 in the Regulation of Proteasome Activity and Localization in Response to DNA Damage.	TNIK TPR U2AF2 ADAR TBC1D10B AAAS TJP2	5.93e-07	131	128	7	28031328
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RANBP2 ANK3 NEDD1 C6orf132 FAM193A ALMS1 KIAA1217 SVIL AHNAK2	6.14e-07	263	128	9	34702444
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	KDM3B AHDC1 CIC EMSY BAP1 FOXP4 KMT2D MGA HCFC1	7.18e-07	268	128	9	33640491
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5AC	9.66e-07	6	128	3	19110483
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SZT2 KDM3B MUC16 R3HDM2 CIC PDLIM5 KMT2D FAM193A AGFG1 MUC3A FHIP1A UNC80	1.02e-06	552	128	12	10737800
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TPR U2AF2 ADAR EMSY BAZ2A ZFHX3 MGA SPEN HCFC1	1.13e-06	283	128	9	30585729
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TPR RANBP2 CALD1 MAFK DCP2 NUP62 NEDD1 SPAG5 HNRNPU BAP1 STRN PHF20L1 SVIL ITSN2 SYCP1 HCFC1 ZMYM4	1.24e-06	1155	128	17	20360068
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DMXL2 FN1 CALD1 ANK3 GIT1 PDLIM5 HNRNPU STRN SNAP91 KIAA1217 VCAN SVIL ITSN2 TJP2 C4A C4B BSN PPP6R2 PLP1	1.29e-06	1431	128	19	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RANBP2 CUX2 CALD1 U2AF2 MYO1B NUP62 PNISR HNRNPU STRN ABCB9 PHF20L1 SNAP91 ITSN2 SYCP1 TAF4 BSN ITIH6 SPEN FCMR	1.44e-06	1442	128	19	35575683
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TNIK TTF2 KDM3B NR4A1 FCHO2 NEDD1 PNISR PDLIM5 MAP3K1 WDR45 AAAS KIAA1217 AGFG1 TJP2 PPP6R2 MRTFA	1.45e-06	1038	128	16	26673895
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	TPR KDM3B U2AF2 ADAR KMT2D ZFHX3 HCFC1 ZMYM4	1.68e-06	220	128	8	35785414
Pubmed	ELYS is a dual nucleoporin/kinetochore protein required for nuclear pore assembly and proper cell division.	TPR RANBP2 NUP62	1.69e-06	7	128	3	17098863
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	TTF2 RANBP2 U2AF2 RREB1 CIC PDLIM5 HNRNPU BAZ2A ZFHX3 TAF4 MGA HCFC1	1.79e-06	583	128	12	29844126
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNIK DMXL2 CUX2 KDM3B BAP1 ALMS1 UNC80 MRTFA	1.99e-06	225	128	8	12168954
Pubmed	Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase.	TPR RANBP2 NUP62 AAAS	2.09e-06	25	128	4	10601273
Pubmed	Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.	TPR RANBP2 NUP62 AAAS	2.46e-06	26	128	4	12228227
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TPR COBLL1 U2AF2 MYO1B ADAR KMT2D SLC15A1 SYCP1	2.66e-06	234	128	8	36243803
Pubmed	Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore.	TPR RANBP2 NUP62	2.69e-06	8	128	3	31375530
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	RANBP2 CALD1 GIT1 ICE2 U2AF2 ADAR PDLIM5 FAM193A AGFG1 TJP2 MGA SPEN AHNAK2	2.92e-06	724	128	13	36232890
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MAN2B1 SZT2 MYOM3 THAP8 KDM3B AHDC1 C2CD2 CIC C6orf132 BAP1 ITPR3 RGMA KMT2D SPEN HCFC1 AHNAK2	3.23e-06	1105	128	16	35748872
Pubmed	Integrated structural analysis of the human nuclear pore complex scaffold.	TPR RANBP2 NUP62 AAAS	4.45e-06	30	128	4	24315095
Pubmed	The Structure Inventory of the Nuclear Pore Complex.	TPR RANBP2 NUP62 AAAS	4.45e-06	30	128	4	27016207
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	JCAD LRRC37A3 KDM3B MUC16 CIC ITPR3 KMT2D AAAS ITSN2 BSN SPEN AHNAK2	4.49e-06	638	128	12	31182584
Pubmed	Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.	KMT2D TAF4 MGA HCFC1	5.10e-06	31	128	4	15960975
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	TPR CALD1 PDLIM5 KIAA1217 TJP2 AHNAK2	5.20e-06	118	128	6	30979931
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR RANBP2 EMC3 CALD1 U2AF2 MYO1B NUP62 ADAR HNRNPU ITPR3 AAAS SVIL TJP2 MGA SPEN	5.83e-06	1024	128	15	24711643
Pubmed	A census of human transcription factors: function, expression and evolution.	CUX2 MAFK THAP8 POU2F1 NR4A1 RREB1 CIC OTP FOXP4 KMT2D SP9 ZFHX3 MGA FOXP3	6.86e-06	908	128	14	19274049
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	AHDC1 EMSY PHC3 TAF4 MGA ZMYM4	6.91e-06	124	128	6	20850016
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	JCAD RANBP2 EMC3 ANK3 MYO1B FCHO2 CIC ITPR3 TBC1D10B KMT2D AAAS PTPRJ SVIL PPP6R2 PHLPP2	7.77e-06	1049	128	15	27880917
Pubmed	Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.	CUX2 NR4A1 OTP FOXP4 SP9 ZFHX3	9.07e-06	130	128	6	19386638
Pubmed	Development, maturation, and necessity of transcription factors in the mouse suprachiasmatic nucleus.	NR4A1 OTP FOXP4 BAZ2A ZFHX3	9.97e-06	77	128	5	21525287
Pubmed	The Immunological Organ Environment Dictates the Molecular and Cellular Pathways of Cytotoxic Antibody Activity.	NR4A1 C4A C4B	1.05e-05	12	128	3	31801071
Pubmed	Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways.	CUX2 NR4A1 OTP FOXP4 SP9 ZFHX3	1.08e-05	134	128	6	19030180
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	MAN2B1 GIT1 AHDC1 FOXP4 AAAS TJP2 MGA MRTFA AHNAK2	1.18e-05	378	128	9	34315543
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	TNIK FN1 COBLL1 DCP2 U2AF2 MYO1B PDLIM5 MAP3K1 PHC3 TBC1D10B SVIL TJP2 COL14A1 C4B MUC5AC ALK HCFC1	1.20e-05	1371	128	17	36244648
Pubmed	Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.	RANBP2 CALD1 SHTN1 PDLIM5 HNRNPU HCFC1	1.22e-05	137	128	6	37039823
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	1.34e-05	2	128	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	1.34e-05	2	128	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	1.34e-05	2	128	2	15998580
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	1.34e-05	2	128	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	1.34e-05	2	128	2	19933335
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	1.34e-05	2	128	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	1.34e-05	2	128	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	1.34e-05	2	128	2	12207352
Pubmed	Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus alpha-trans-induction factor (VP16).	POU2F1 HCFC1	1.34e-05	2	128	2	8454622
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	1.34e-05	2	128	2	22220206
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	1.34e-05	2	128	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	1.34e-05	2	128	2	22387014
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	1.34e-05	2	128	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	1.34e-05	2	128	2	23918728
Pubmed	Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas.	FN1 ALK	1.34e-05	2	128	2	27469327
Pubmed	Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.	BAP1 HCFC1	1.34e-05	2	128	2	19188440
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	1.34e-05	2	128	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	1.34e-05	2	128	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	1.34e-05	2	128	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	1.34e-05	2	128	2	6950384
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	1.34e-05	2	128	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	1.34e-05	2	128	2	8428773
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	1.34e-05	2	128	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	1.34e-05	2	128	2	21345967
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	1.34e-05	2	128	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	1.34e-05	2	128	2	2302180
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	1.34e-05	2	128	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	1.34e-05	2	128	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	1.34e-05	2	128	2	29080553
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	1.34e-05	2	128	2	6589636
Pubmed	Characterization of four novel CAG repeat-containing cDNAs.	R3HDM2 KMT2D	1.34e-05	2	128	2	8595911
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	1.34e-05	2	128	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	1.34e-05	2	128	2	17728371
Pubmed	Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.	POU2F1 HCFC1	1.34e-05	2	128	2	9199328
Pubmed	Structure and organization of the C4 genes.	C4A C4B	1.34e-05	2	128	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	1.34e-05	2	128	2	6149581
Interaction	NUP43 interactions	RANBP2 SZT2 MUC19 CHD9 NUP62 AHDC1 EMSY SPAG5 PHC3 KMT2D RESF1 PHF20L1 BAZ2A ZFHX3 TAF4 MGA PPP6R2 SPEN HCFC1 ZMYM4 AHNAK2 PDZD2	5.32e-11	625	127	22	int:NUP43
Interaction	RCOR1 interactions	TNIK TPR RANBP2 RREB1 SHTN1 CIC HNRNPU BAP1 KMT2D FAM193A RESF1 ALMS1 TET1 ZFHX3 MGA SPEN ZMYM4 MRTFA FOXP3	2.88e-10	494	127	19	int:RCOR1
Interaction	PFN1 interactions	TPR TTF2 RANBP2 FN1 COBLL1 NUP62 FCHO2 SHTN1 PDLIM5 SPAG5 C6orf132 BAP1 ALMS1 KIAA1217 TJP2 PPP6R2 ZMYM4 MRTFA AHNAK2	4.75e-10	509	127	19	int:PFN1
Interaction	NAA40 interactions	TNIK TPR TTF2 RANBP2 CALD1 KDM3B MYO1B NUP62 NEDD1 SHTN1 ADAR CIC EMSY PDLIM5 SPAG5 HNRNPU PHC3 FAM193A ALMS1 BAZ2A KIAA1217 AGFG1 PPP6R2 HCFC1 AHNAK2	1.85e-09	978	127	25	int:NAA40
Interaction	PHF21A interactions	TPR RANBP2 NUP62 RREB1 CIC SPAG5 BAP1 KMT2D FAM193A RESF1 ALMS1 TET1 ZFHX3 MGA MRTFA	4.48e-09	343	127	15	int:PHF21A
Interaction	HDAC1 interactions	TPR RANBP2 FN1 MAFK U2AF2 POU2F1 NR4A1 RREB1 SHTN1 CIC EMSY PDLIM5 SPAG5 HNRNPU BAP1 KMT2D ALMS1 PHF20L1 BAZ2A TET1 ZFHX3 MGA SPEN HCFC1 MRTFA FOXP3	4.96e-09	1108	127	26	int:HDAC1
Interaction	FEV interactions	POU2F1 RREB1 CIC EMSY BAP1 PHC3 FOXP4 KMT2D ZFHX3 TAF4 MGA ZMYM4	6.15e-09	203	127	12	int:FEV
Interaction	EGR2 interactions	RREB1 AHDC1 EMSY FOXP4 KMT2D RESF1 TET1 ZFHX3 MGA HCFC1 ZMYM4	1.13e-08	171	127	11	int:EGR2
Interaction	KDM1A interactions	TNIK TPR RANBP2 RREB1 SHTN1 CIC SPAG5 BAP1 PHC3 KMT2D FAM193A RESF1 ALMS1 PHF20L1 KIAA1217 TET1 ITSN2 ZFHX3 MGA FIGNL1 ZMYM4 MRTFA FOXP3	2.09e-08	941	127	23	int:KDM1A
Interaction	ZYX interactions	FN1 U2AF2 MYO1B PDLIM5 SPAG5 TBC1D10B ALMS1 KIAA1217 SVIL TJP2 PPP6R2 MRTFA AHNAK2	1.65e-07	329	127	13	int:ZYX
Interaction	NFIX interactions	POU2F1 RREB1 CIC EMSY BAP1 KMT2D ZFHX3 TAF4 MGA SPEN ZMYM4	2.06e-07	227	127	11	int:NFIX
Interaction	AR interactions	TPR FN1 KDM3B U2AF2 POU2F1 MYO1B RREB1 ADAR AHDC1 CIC EMSY HNRNPU BAP1 FOXP4 KMT2D AAAS KIAA1217 SVIL ZFHX3 MGA HCFC1 ZMYM4	2.40e-07	992	127	22	int:AR
Interaction	BICD2 interactions	TNIK TPR TTF2 RANBP2 CALD1 NUP62 FCHO2 NEDD1 PDLIM5 ALMS1 KIAA1217 SVIL TJP2 ALK	5.08e-07	426	127	14	int:BICD2
Interaction	ELF4 interactions	CIC EMSY BAP1 KMT2D TAF4 MGA ZMYM4 FOXP3	6.70e-07	115	127	8	int:ELF4
Interaction	TLE3 interactions	ANK3 MYO1B AHDC1 CIC EMSY BAP1 PHC3 KMT2D FAM193A ZFHX3 TAF4 SPEN FIGNL1	7.54e-07	376	127	13	int:TLE3
Interaction	ELK3 interactions	POU2F1 RREB1 CIC EMSY BAP1 FOXP4 TAF4 MGA	9.27e-07	120	127	8	int:ELK3
Interaction	MYB interactions	TTF2 CIC EMSY BAP1 KMT2D ZFHX3 MGA ZMYM4	2.02e-06	133	127	8	int:MYB
Interaction	EZR interactions	TNIK FN1 CALD1 ANK3 COBLL1 U2AF2 MYO1B FCHO2 C6orf132 BAP1 WDR45 SVIL ITSN2 PTPRQ PHLPP2	2.15e-06	553	127	15	int:EZR
Interaction	LHX2 interactions	RREB1 CIC FOXP4 KMT2D ZFHX3 OSMR MGA ZMYM4 MRTFA	2.43e-06	183	127	9	int:LHX2
Interaction	NR3C1 interactions	JCAD LRRC37A3 KDM3B MUC16 POU2F1 CHD9 NUP62 NR4A1 CIC HNRNPU BAP1 ITPR3 KMT2D AAAS SVIL ITSN2 BSN SPEN AHNAK2 FOXP3	2.95e-06	974	127	20	int:NR3C1
Interaction	BICD1 interactions	TNIK JCAD RANBP2 SYNPO2 CALD1 NEDD1 PDLIM5 PROSER3 ITSN2 TJP2	4.23e-06	250	127	10	int:BICD1
Interaction	AP2B1 interactions	TNIK FN1 ICE2 FCHO2 BAP1 FAM193A ALMS1 SNAP91 ITSN2 AGFG1 PPP6R2 FOXP3	4.31e-06	373	127	12	int:AP2B1
Interaction	SMC5 interactions	TPR RANBP2 CALD1 U2AF2 NUP62 RREB1 ADAR CIC EMSY HNRNPU PHC3 SNAP91 BAZ2A AGFG1 TAF4 MGA SPEN ALK HCFC1 ZMYM4	4.39e-06	1000	127	20	int:SMC5
Interaction	SYNE3 interactions	JCAD RANBP2 NUP62 NCSTN NEDD1 SPAG5 ITPR3 AAAS FAM193A ALMS1 PROSER3 KIAA1217 COL14A1	4.72e-06	444	127	13	int:SYNE3
Interaction	KLF8 interactions	POU2F1 RREB1 CIC EMSY BAP1 FOXP4 KMT2D TAF4 MGA SPEN ZMYM4	7.67e-06	329	127	11	int:KLF8
Interaction	KCNA3 interactions	TPR TTF2 RANBP2 CALD1 ANK3 SZT2 ICE2 COBLL1 CHD9 MYO1B FCHO2 SHTN1 PDLIM5 HNRNPU TBC1D10B BSN SPEN HCFC1	8.96e-06	871	127	18	int:KCNA3
Interaction	IK interactions	TPR RANBP2 U2AF2 NUP62 NCSTN CIC HNRNPU SPEN FOXP3	9.04e-06	215	127	9	int:IK
Interaction	HNF4A interactions	MUC19 RREB1 CIC EMSY BAP1 KMT2D TAF4 MGA SPEN ZMYM4	9.78e-06	275	127	10	int:HNF4A
Interaction	TERF2IP interactions	KDM3B RREB1 CIC EMSY HNRNPU BAP1 RGMA PHC3 BAZ2A TAF4 MGA SPEN HCFC1 ZMYM4	1.03e-05	552	127	14	int:TERF2IP
Interaction	DYRK1A interactions	TPR JCAD FN1 CALD1 ICE2 PNISR CIC PDLIM5 MAP3K1 KMT2D KIAA1217 TJP2 PLP1 AHNAK2	1.03e-05	552	127	14	int:DYRK1A
Interaction	IMPDH2 interactions	TTF2 FN1 U2AF2 NR4A1 SHTN1 PDLIM5 BAP1 WDR45 ALMS1 KIAA1217 TJP2 TAF4	1.42e-05	420	127	12	int:IMPDH2
Interaction	KLF3 interactions	RREB1 CIC EMSY FOXP4 KMT2D ZFHX3 TAF4 MGA ZMYM4	1.45e-05	228	127	9	int:KLF3
Interaction	YAP1 interactions	TPR JCAD TTF2 CALD1 ANK3 KDM3B MYO1B SHTN1 ADAR PDLIM5 HNRNPU KMT2D BAZ2A TET1 TJP2 TAF4 MGA SPEN HCFC1 ZMYM4	1.67e-05	1095	127	20	int:YAP1
Interaction	VASP interactions	FN1 COBLL1 NR4A1 SPAG5 C6orf132 TBC1D10B ALMS1 SVIL TJP2 MRTFA	1.74e-05	294	127	10	int:VASP
Interaction	YWHAH interactions	JCAD FN1 GIT1 COBLL1 KDM3B R3HDM2 NUP62 SHTN1 CIC C6orf132 BAP1 TBC1D10B RESF1 ALMS1 KIAA1217 SVIL TET1 AGFG1 TJP2 AHNAK2	1.83e-05	1102	127	20	int:YWHAH
Interaction	CDH1 interactions	JCAD CALD1 ANK3 COBLL1 MYO1B SHTN1 PDLIM5 C6orf132 TBC1D10B PTPRJ KIAA1217 SVIL PTPRQ AGFG1 TJP2 HCFC1	2.68e-05	768	127	16	int:CDH1
Interaction	NUP214 interactions	TPR RANBP2 NUP62 ADAR EMSY STRN AAAS FOXP3	3.34e-05	195	127	8	int:NUP214
Interaction	YWHAG interactions	JCAD SYNPO2 FN1 GIT1 COBLL1 DCP2 KDM3B R3HDM2 NUP62 SHTN1 CIC MAP3K1 C6orf132 BAP1 TBC1D10B ALMS1 SVIL TET1 AGFG1 TJP2 AHNAK2	3.38e-05	1248	127	21	int:YWHAG
Interaction	CRX interactions	SZT2 POU2F1 RREB1 FOXP4 KMT2D ZFHX3 MGA SPEN ZMYM4	3.39e-05	254	127	9	int:CRX
Interaction	FOXL1 interactions	RANBP2 POU2F1 MYO1B ADAR CIC FOXP4 KMT2D ZFHX3	3.46e-05	196	127	8	int:FOXL1
Interaction	BAG2 interactions	TNIK TTF2 FN1 KDM3B POU2F1 RREB1 NEDD1 CIC PDLIM5 BAP1 PHC3 STRN SPEN MRTFA	3.85e-05	622	127	14	int:BAG2
Interaction	CALD1 interactions	TPR CALD1 MYO1B BAP1 ITPR3 STRN SVIL TJP2 FIGNL1	4.71e-05	265	127	9	int:CALD1
Interaction	ASH2L interactions	MAFK MYOM3 EMSY BAP1 KMT2D TAF4 MGA HCFC1 FOXP3	4.71e-05	265	127	9	int:ASH2L
Interaction	CBX3 interactions	FN1 COBLL1 CHD9 RREB1 AHDC1 CIC PDLIM5 HNRNPU BAP1 BAZ2A TAF4 MGA SPEN ZMYM4	5.79e-05	646	127	14	int:CBX3
Interaction	TPR interactions	TNIK TPR RANBP2 FN1 CALD1 U2AF2 NUP62 HNRNPU BAP1	7.40e-05	281	127	9	int:TPR
Interaction	H3-3A interactions	KDM3B U2AF2 POU2F1 CHD9 RREB1 CIC EMSY KMT2D PHF20L1 BAZ2A TAF4 MGA SPEN HCFC1 ZMYM4	7.58e-05	749	127	15	int:H3-3A
Interaction	CLTA interactions	FN1 DCP2 FCHO2 NEDD1 BAP1 WDR45 ALMS1 ITSN2 AGFG1 AHNAK2	7.79e-05	351	127	10	int:CLTA
Interaction	TBR1 interactions	CIC BAP1 FOXP4 KMT2D ZFHX3 ZMYM4	8.10e-05	113	127	6	int:TBR1
Interaction	CAMK2D interactions	TNIK MYO1B NEDD1 BAP1 ITPR3 PRKAG3 HCFC1 FOXP3	8.33e-05	222	127	8	int:CAMK2D
Interaction	AVIL interactions	MYO1B ALMS1 SVIL FIGNL1	8.46e-05	37	127	4	int:AVIL
Interaction	SNX27 interactions	MAN2B1 GIT1 AHDC1 FOXP4 AAAS PTPRQ TJP2 C4A MGA MRTFA PHLPP2 AHNAK2	9.17e-05	509	127	12	int:SNX27
Interaction	HCFC1 interactions	POU2F1 ADAR CIC BAP1 KMT2D PHF20L1 TAF4 MGA HCFC1	1.02e-04	293	127	9	int:HCFC1
Interaction	HDAC2 interactions	TNIK GIT1 MAFK RREB1 CIC EMSY HNRNPU BAP1 PHF20L1 TET1 AGFG1 COL14A1 SPEN HCFC1 AHNAK2 FOXP3	1.09e-04	865	127	16	int:HDAC2
Interaction	TLX1 interactions	RREB1 CIC BAP1 FOXP4 KMT2D ZFHX3 ZMYM4	1.23e-04	175	127	7	int:TLX1
Interaction	CSF3 interactions	PTPRJ COL14A1 AHNAK2	1.29e-04	16	127	3	int:CSF3
Interaction	PAX7 interactions	POU2F1 RREB1 CIC FOXP4 KMT2D ZFHX3	1.35e-04	124	127	6	int:PAX7
Interaction	ELF1 interactions	EMSY BAP1 TAF4 MGA ZMYM4 FOXP3	1.48e-04	126	127	6	int:ELF1
Interaction	NINL interactions	TTF2 GIT1 THAP8 NEDD1 SPAG5 ALMS1 PROSER3 KIAA1217 SVIL ITSN2 ZFHX3	1.55e-04	458	127	11	int:NINL
Interaction	AMOT interactions	JCAD MYOM3 SPAG5 BAP1 WDR45 FAM193A ALMS1 PHF20L1 TJP2	1.63e-04	312	127	9	int:AMOT
Interaction	CHEK2 interactions	TPR MYO1B NR4A1 CIC HNRNPU BAP1 KMT2D SVIL	1.89e-04	250	127	8	int:CHEK2
Interaction	PAX2 interactions	POU2F1 CIC FOXP4 KMT2D MGA	2.01e-04	85	127	5	int:PAX2
Interaction	FAM107B interactions	CALD1 U2AF2 TJP2	2.20e-04	19	127	3	int:FAM107B
Interaction	GSC interactions	POU2F1 RREB1 FOXP4 KMT2D ZFHX3	2.24e-04	87	127	5	int:GSC
Interaction	KLF5 interactions	CIC BAP1 FOXP4 KMT2D MGA HCFC1 ZMYM4	2.39e-04	195	127	7	int:KLF5
Interaction	PHLPP1 interactions	TPR RANBP2 FCHO2 SHTN1 SPAG5 KIAA1217 HCFC1 PHLPP2 AHNAK2	2.65e-04	333	127	9	int:PHLPP1
Interaction	MYH9 interactions	FN1 CALD1 KDM3B U2AF2 CHD9 MYO1B FCHO2 AHDC1 C2CD2 HNRNPU BAP1 ITPR3 SVIL ALK	2.90e-04	754	127	14	int:MYH9
Interaction	CEBPA interactions	TTF2 RANBP2 MAFK KDM3B POU2F1 CHD9 RREB1 NEDD1 ADAR AHDC1 CIC EMSY HNRNPU KMT2D RESF1 TAF4 SPEN HCFC1 ZMYM4	2.94e-04	1245	127	19	int:CEBPA
Interaction	ZMYM2 interactions	TNIK RREB1 ADAR CIC FOXP4 RESF1 MGA ZMYM4	3.25e-04	271	127	8	int:ZMYM2
Interaction	POU5F1 interactions	TPR TTF2 MUC16 EMSY HNRNPU ITPR3 FOXP4 RESF1 TET1 ZFHX3 MGA HCFC1	3.26e-04	584	127	12	int:POU5F1
Interaction	KRT18 interactions	FN1 EMSY SPAG5 HNRNPU BAP1 ITPR3 ALMS1 KIAA1217 SVIL ALK	3.26e-04	419	127	10	int:KRT18
Interaction	TOP3B interactions	MAN2B1 SZT2 MYOM3 THAP8 KDM3B MYO1B R3HDM2 NEDD1 AHDC1 C2CD2 CIC HNRNPU C6orf132 BAP1 ITPR3 RGMA KMT2D SVIL SPEN HCFC1 AHNAK2	3.35e-04	1470	127	21	int:TOP3B
Interaction	KAT8 interactions	TPR PHF20L1 BAZ2A HCFC1 FOXP3	3.38e-04	95	127	5	int:KAT8
Interaction	SPTBN1 interactions	TNIK FN1 CALD1 ANK3 POU2F1 ADAR CIC PDLIM5 BAP1 SVIL	3.39e-04	421	127	10	int:SPTBN1
Interaction	WWTR1 interactions	TTF2 CALD1 ANK3 SHTN1 ADAR EMSY PDLIM5 KMT2D ALMS1 HCFC1	3.45e-04	422	127	10	int:WWTR1
Interaction	NFIC interactions	POU2F1 RREB1 CIC FOXP4 KMT2D MGA ZMYM4	3.75e-04	210	127	7	int:NFIC
Interaction	RNF43 interactions	RANBP2 ANK3 U2AF2 NEDD1 C6orf132 FAM193A ALMS1 KIAA1217 SVIL AHNAK2	3.79e-04	427	127	10	int:RNF43
Interaction	GAPDH interactions	RANBP2 FN1 CALD1 KDM3B POU2F1 HNRNPU BAP1 SVIL TET1 ZFHX3 OSMR HCFC1 FCMR	3.98e-04	686	127	13	int:GAPDH
Interaction	SEC13 interactions	TPR SZT2 CIC SPAG5 BAP1 AAAS FOXP3	4.44e-04	216	127	7	int:SEC13
Interaction	RDX interactions	CALD1 COBLL1 MYO1B HNRNPU C6orf132 BAP1 SVIL PHLPP2	4.44e-04	284	127	8	int:RDX
Interaction	ACTB interactions	JCAD TTF2 FN1 CALD1 COBLL1 U2AF2 MYO1B NEDD1 SHTN1 PDLIM5 HNRNPU C6orf132 BAP1 ALMS1 SVIL ALK MRTFA	4.58e-04	1083	127	17	int:ACTB
Interaction	NIN interactions	TTF2 NUP62 NEDD1 SPAG5 ALMS1 PROSER3 KIAA1217 SVIL MGA	4.58e-04	359	127	9	int:NIN
Interaction	LATS1 interactions	JCAD MYO1B FAM193A ALMS1 KIAA1217 SVIL PTPRQ TJP2 TAF4 MGA	4.79e-04	440	127	10	int:LATS1
Interaction	KRT8 interactions	FN1 POU2F1 NUP62 SPAG5 BAP1 ITPR3 PHC3 FAM193A ALMS1 PPP6R2	4.87e-04	441	127	10	int:KRT8
Interaction	CBX1 interactions	KDM3B AHDC1 EMSY HNRNPU BAP1 MGA HCFC1 ZMYM4	4.87e-04	288	127	8	int:CBX1
Interaction	TJP2 interactions	JCAD TTF2 CALD1 NEDD1 PDLIM5 ALMS1 SVIL TJP2	4.87e-04	288	127	8	int:TJP2
Interaction	GBF1 interactions	TPR RANBP2 CALD1 SZT2 SHTN1 PDLIM5 HNRNPU BAP1 WDR45 AHNAK2	4.96e-04	442	127	10	int:GBF1
Interaction	PRPF40A interactions	TPR FN1 ICE2 U2AF2 NCSTN HNRNPU BAP1 ZFHX3 SPEN PDZD2	5.32e-04	446	127	10	int:PRPF40A
Interaction	ERG interactions	ADAR CIC EMSY HNRNPU FOXP4 KMT2D RESF1	5.37e-04	223	127	7	int:ERG
Interaction	DDA1 interactions	ANK3 KDM3B U2AF2 POU2F1 AHDC1 CIC BAP1 PHF20L1 FIGNL1	5.47e-04	368	127	9	int:DDA1
Interaction	H3-4 interactions	KDM3B RREB1 AHDC1 EMSY HNRNPU PHC3 SVIL TAF4 MGA ZMYM4	5.51e-04	448	127	10	int:H3-4
Interaction	FOXK2 interactions	TPR CIC EMSY BAP1 KMT2D PHF20L1 HCFC1	5.67e-04	225	127	7	int:FOXK2
Interaction	SOX5 interactions	POU2F1 CIC FOXP4 KMT2D ZFHX3 ZMYM4	5.71e-04	162	127	6	int:SOX5
Interaction	UBE2A interactions	TNIK TPR U2AF2 ADAR TBC1D10B AAAS TJP2	5.82e-04	226	127	7	int:UBE2A
Interaction	CTNNB1 interactions	TNIK JCAD RANBP2 ANK3 MYO1B NR4A1 PDLIM5 HNRNPU BAP1 KMT2D FAM193A PTPRJ KIAA1217 SVIL PTPRQ TJP2	6.10e-04	1009	127	16	int:CTNNB1
Interaction	YY1 interactions	CIC EMSY BAP1 PHC3 FOXP4 TAF4 MGA HCFC1 ZMYM4 FOXP3	6.10e-04	454	127	10	int:YY1
Interaction	SNRPA1 interactions	TPR RANBP2 ICE2 U2AF2 ADAR EMSY HNRNPU BAP1	6.37e-04	300	127	8	int:SNRPA1
Interaction	RRP7A interactions	TPR RANBP2 U2AF2 NCSTN HNRNPU	6.63e-04	110	127	5	int:RRP7A
Interaction	BEND3 interactions	TNIK CIC BAZ2A ZFHX3 FOXP3	6.90e-04	111	127	5	int:BEND3
Interaction	SNRNP40 interactions	U2AF2 PNISR AHDC1 EMSY PHC3 PHF20L1 BAZ2A ITSN2 ZFHX3 TAF4 MGA SPEN	7.05e-04	637	127	12	int:SNRNP40
Interaction	LY6G5B interactions	FN1 DCP2 NEDD1	7.14e-04	28	127	3	int:LY6G5B
Cytoband	7q22	RELN MUC12 MUC3A	1.66e-04	38	128	3	7q22
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC12 MUC17 MUC3A MUC5AC	4.63e-10	21	85	6	648
GeneFamily	Nucleoporins	TPR RANBP2 NUP62 AAAS	1.48e-05	32	85	4	1051
GeneFamily	Fibronectin type III domain containing	FN1 MYOM3 PTPRJ PTPRQ COL14A1 OSMR	1.07e-04	160	85	6	555
GeneFamily	PDZ domain containing	SYNPO2 PDLIM5 TJP2 AHNAK2 PDZD2	7.51e-04	152	85	5	1220
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	7.70e-04	9	85	2	1234
GeneFamily	WD repeat domain containing	DMXL2 NEDD1 WDR93 WDR45 STRN AAAS	1.47e-03	262	85	6	362
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	RANBP2 DMXL2 KDM3B CHD9 MYO1B R3HDM2 PNISR AHDC1 C2CD2 PDLIM5 FAM193A ITSN2 AGFG1 TJP2 ZFHX3 TAF4 OSMR SPEN ZMYM4 MRTFA PHLPP2	1.11e-09	856	128	21	M4500
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL	TNFAIP8L3 GIT1 COBLL1 NR4A1 SHTN1 CIC PDLIM5 ITPR3 PTPRQ C4A C4B PHLPP2 AHNAK2 PDZD2 FCMR	1.88e-06	704	128	15	M45672
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	TNFAIP8L3 ANK3 GIT1 COBLL1 SHTN1 AHDC1 ITPR3 FOXP4 SVIL ITSN2 PTPRQ AGFG1 C4A C4B OSMR PHLPP2 PDZD2	4.21e-06	955	128	17	M45680
Coexpression	GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN	MAN2B1 CD300A CHD9 EVI2B R3HDM2 PDLIM5 PHC3 ZFHX3	6.53e-06	200	128	8	M8056
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	SZT2 U2AF2 NUP62 GRAMD4 CIC HNRNPU KMT2D PPP6R2 MCTP2 HCFC1	6.58e-06	338	128	10	M17094
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	FN1 CALD1 ANK3 COBLL1 MYO1B FCHO2 PDLIM5 PHF20L1 KIAA1217 ITSN2 TJP2 AHNAK2	7.07e-06	504	128	12	M2157
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	CHD9 MYO1B R3HDM2 PNISR C2CD2 ITSN2 TJP2 TAF4 SPEN ZMYM4 PHLPP2	1.88e-05	466	128	11	M13522
Coexpression	YAGUE_PRETUMOR_DRUG_RESISTANCE_DN	CALD1 RREB1 VCAN	3.14e-05	13	128	3	M2070
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL	SYNPO2 THAP8 NR4A1 SSC5D FOXP4 SVIL PLP1	4.11e-05	189	128	7	M45678
Coexpression	GSE27786_BCELL_VS_NKCELL_UP	SZT2 MAP3K1 ITPR3 KIAA1217 MGA FHIP1A ZMYM4	5.88e-05	200	128	7	M4805
Coexpression	GSE4142_PLASMA_CELL_VS_GC_BCELL_UP	NR4A1 TBC1D10B FAM193A PHF20L1 SYCP1 ZFHX3 PHLPP2	5.88e-05	200	128	7	M6390
Coexpression	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP	TNIK CD300A RREB1 PHC3 COL14A1 FCMR FOXP3	5.88e-05	200	128	7	M4332
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	RANBP2 AHDC1 PDLIM5 FAM193A AGFG1	6.16e-05	85	128	5	M10575
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	CALD1 KDM3B CHD9 MYO1B SHTN1 HNRNPU PTPRJ TJP2 ZFHX3 PDZD2	1.02e-04	467	128	10	M1347
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	TTF2 SYNPO2 FN1 CALD1 NEDD1 PHF20L1 VCAN FIGNL1	1.31e-04	305	128	8	M19875
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	JCAD FN1 HNRNPU ALMS1 SYCP1 ZFHX3 OSMR PPP6R2 PLP1 FCMR	1.32e-04	482	128	10	M12144
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	CALD1 KDM3B CHD9 MYO1B SHTN1 HNRNPU PTPRJ TJP2 ZFHX3 PDZD2	1.37e-04	484	128	10	MM999
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_500	JCAD NR4A1 KIAA1217 VCAN SVIL	1.20e-06	32	126	5	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_500
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	CALD1 MUC16 PTPRQ TJP2 C4A C4B OSMR FHIP1A	6.59e-08	185	128	8	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	CALD1 MUC16 PTPRQ TJP2 C4A C4B OSMR FHIP1A	7.77e-08	189	128	8	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC19 MUC16 STPG2 PRKAG3 COL14A1 ITIH6 MUC3A UNC80	9.89e-08	195	128	8	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC19 MUC16 STPG2 PRKAG3 COL14A1 ITIH6 MUC3A UNC80	9.89e-08	195	128	8	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN TNFAIP8L3 CALD1 VCAN SP9 COL14A1 ALK	4.71e-07	163	128	7	8d17f44faf0549fe71a9a45f811f50d767275414
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	RELN TNFAIP8L3 OTP COL14A1 ALK FOXP3	5.69e-07	104	128	6	b5ca6e589f414e549f4990fe334d4ee54829b298
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	SYNPO2 FN1 CALD1 VCAN SVIL COL14A1 ZFHX3	9.18e-07	180	128	7	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	ANK3 MYO1B C6orf132 KIAA1217 PTPRQ OSMR FHIP1A	9.88e-07	182	128	7	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK SYNPO2 CALD1 PDLIM5 VCAN SVIL OSMR	1.06e-06	184	128	7	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	SYNPO2 CALD1 ANK3 MYOM3 PDLIM5 SVIL PDZD2	1.06e-06	184	128	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MUC12 C6orf132 ITPR3 SVIL COL14A1 FHIP1A	1.18e-06	187	128	7	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MUC12 C6orf132 ITPR3 SVIL COL14A1 FHIP1A	1.18e-06	187	128	7	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MUC12 C6orf132 ITPR3 SVIL COL14A1 FHIP1A	1.18e-06	187	128	7	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ANK3 COBLL1 MYO1B KIAA1217 OSMR MCTP2 FHIP1A	1.41e-06	192	128	7	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	ANK3 COBLL1 MYO1B KIAA1217 OSMR FHIP1A PDZD2	1.41e-06	192	128	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MAP3K1 ITPR3 STRN PTPRJ SLC15A1 SVIL	1.46e-06	193	128	7	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MAP3K1 C6orf132 ITPR3 STRN VCAN SVIL	1.46e-06	193	128	7	263d185af6ed80e639f864e4966268e0862c61dc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MAP3K1 C6orf132 ITPR3 STRN VCAN SVIL	1.46e-06	193	128	7	80e058c224749b5fe0ba3e944b48317c2371cb63
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MAP3K1 C6orf132 ITPR3 STRN VCAN SVIL	1.46e-06	193	128	7	b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MAP3K1 ITPR3 STRN PTPRJ SLC15A1 SVIL	1.46e-06	193	128	7	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 CUX2 CALD1 MYO1B PDLIM5 KIAA1217 COL14A1	1.57e-06	195	128	7	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYNPO2 NPY5R CALD1 MYO1B C2CD2 PDLIM5 OSMR	1.57e-06	195	128	7	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 CUX2 CALD1 MYO1B PDLIM5 KIAA1217 COL14A1	1.57e-06	195	128	7	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNPO2 FN1 CALD1 COBLL1 MYO1B SVIL COL14A1	1.57e-06	195	128	7	d760d1423f9a8a373fe7b250ea9b1d67a0c0059f
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SYNPO2 CALD1 NR4A1 SSC5D SVIL ZFHX3 PLP1	1.73e-06	198	128	7	637f11e292b90d86cdc0d0d828eb26f38289c25b
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SYNPO2 CALD1 MYO1B NR4A1 SVIL ZFHX3 PLP1	1.73e-06	198	128	7	c9c96066c7fa897b583657f0b77ea093920ae9ba
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FN1 CALD1 MYO1B SSC5D VCAN COL14A1 OSMR	1.79e-06	199	128	7	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SYNPO2 TNFAIP8L3 CALD1 NR4A1 SSC5D SVIL PLP1	1.79e-06	199	128	7	a207b4891881149d4c50721310690fd794157723
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 CALD1 NR4A1 RGMA VCAN COL14A1 AHNAK2	1.85e-06	200	128	7	db6281b5d4032116310db379d9175d790994c99c
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 MUC16 STRN PTPRJ KIAA1217 MCTP2 FHIP1A	1.85e-06	200	128	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SYNPO2 FN1 CALD1 ANK3 SSC5D SVIL PLP1	1.85e-06	200	128	7	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 CALD1 NR4A1 RGMA VCAN COL14A1 AHNAK2	1.85e-06	200	128	7	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 CALD1 NR4A1 RGMA VCAN COL14A1 AHNAK2	1.85e-06	200	128	7	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TNFAIP8L3 MUC16 NR4A1 AHDC1 HNRNPU FCMR	3.81e-06	144	128	6	38ff324366ad5be626e3657c1e33277fc36ddd4c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN TNFAIP8L3 CALD1 VCAN SP9 ALK	8.04e-06	164	128	6	08819970174a3eb4eee8e1e675075828665b845e
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	RELN ANK3 PTPRJ KIAA1217 PLP1 ALK	8.32e-06	165	128	6	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	Control\|World / group, cell type (main and fine annotations)	ANK3 COBLL1 MYO1B MUC5AC FHIP1A PDZD2	9.23e-06	168	128	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	RELN ANK3 PTPRJ KIAA1217 CIPC PLP1	9.23e-06	168	128	6	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNPO2 RGMA KIAA1217 ZFHX3 MCTP2 FHIP1A	9.87e-06	170	128	6	84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNPO2 RGMA KIAA1217 ZFHX3 MCTP2 FHIP1A	1.05e-05	172	128	6	cecfe5cf20f317ea01b4604789e07a14481c4cd6
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	RELN ANK3 PTPRJ KIAA1217 PLP1 ALK	1.09e-05	173	128	6	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNPO2 RGMA KIAA1217 ZFHX3 MCTP2 FHIP1A	1.09e-05	173	128	6	95c723b09254ae7131fe5ba0841472502e83269b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNPO2 RGMA KIAA1217 ZFHX3 MCTP2 FHIP1A	1.13e-05	174	128	6	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 CALD1 PDLIM5 KIAA1217 COL14A1 OSMR	1.28e-05	178	128	6	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 SLC15A1 MUC17 MUC3A MUC5AC AHNAK2	1.32e-05	179	128	6	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 SLC15A1 MUC17 MUC3A MUC5AC AHNAK2	1.37e-05	180	128	6	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 SLC15A1 MUC17 MUC3A MUC5AC AHNAK2	1.37e-05	180	128	6	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COBLL1 MUC16 C6orf132 STRN C4B AHNAK2	1.41e-05	181	128	6	330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COBLL1 MUC16 C6orf132 STRN C4B AHNAK2	1.41e-05	181	128	6	3f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 TNFAIP8L3 FN1 CALD1 FOXP4 SVIL	1.41e-05	181	128	6	beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell	wk_08-11-Mesenchymal-Mesothelial-Late_mesothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	TNFAIP8L3 GIT1 PTPRQ C4A BSN AHNAK2	1.45e-05	182	128	6	f8257c884393f168f605d371e0840cfca8d3657e
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	ANK3 C6orf132 KIAA1217 PTPRQ OSMR FHIP1A	1.45e-05	182	128	6	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK RELN SZT2 STRN PTPRJ PLP1	1.55e-05	184	128	6	e33bb572af9dfd11127105f1ac99bc958a7cafbb
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TNIK TPR MAP3K1 PHC3 RESF1 ALMS1	1.64e-05	186	128	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	SYNPO2 FN1 CALD1 PDLIM5 VCAN COL14A1	1.69e-05	187	128	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	JCAD FN1 SSC5D VCAN COL14A1 C4A	1.69e-05	187	128	6	a96495803ba13fcfadd1d83b3cf5774f3fed0a20
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-double_negative_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK MAN2B1 NR4A1 HNRNPU ABCB9 SLC15A1	1.75e-05	188	128	6	e0184d9f6687d7ecb8fc461294ff7208f49c437c
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FN1 SSC5D VCAN COL14A1 C4B AHNAK2	1.75e-05	188	128	6	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 NPY5R CALD1 PDLIM5 KIAA1217 VCAN	1.80e-05	189	128	6	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SYNPO2 FN1 CALD1 MYO1B COL14A1 OSMR	1.80e-05	189	128	6	1ff4f8da572bdc6356e9df9f41a7f62c81d4c570
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO2 CALD1 COBLL1 MYO1B C2CD2 ZFHX3	1.80e-05	189	128	6	de51fbd6fdb24fc4549393cf41a020005444b2aa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 NPY5R CALD1 PDLIM5 KIAA1217 VCAN	1.80e-05	189	128	6	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	SYNPO2 MYOM3 PDLIM5 SNAP91 SVIL PDZD2	1.80e-05	189	128	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CALD1 NR4A1 SVIL COL14A1 C4B	1.85e-05	190	128	6	d13fd234caa3fc69d8a59bc0060cdacdf716ee55
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	SYNPO2 ANK3 MYOM3 PDLIM5 SVIL PDZD2	1.85e-05	190	128	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	POU2F1 MYO1B MAP3K1 TET1 SP9 ZFHX3	1.85e-05	190	128	6	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	SYNPO2 ANK3 MYOM3 PDLIM5 SVIL PDZD2	1.91e-05	191	128	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 CALD1 PDLIM5 KIAA1217 VCAN COL14A1	1.91e-05	191	128	6	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 ITPR3 KIAA1217 PTPRQ FHIP1A PDZD2	1.91e-05	191	128	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK3 COBLL1 MYO1B KIAA1217 FHIP1A PDZD2	1.91e-05	191	128	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 CALD1 PDLIM5 KIAA1217 VCAN COL14A1	1.91e-05	191	128	6	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ANK3 COBLL1 MYO1B KIAA1217 FHIP1A PDZD2	1.97e-05	192	128	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	ANK3 MYO1B C6orf132 KIAA1217 OSMR FHIP1A	1.97e-05	192	128	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	ANK3 MYO1B C6orf132 KIAA1217 OSMR FHIP1A	1.97e-05	192	128	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	TNIK ANK3 MYOM3 PDLIM5 SVIL FHIP1A	1.97e-05	192	128	6	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK ANK3 MYOM3 PDLIM5 SVIL FHIP1A	2.03e-05	193	128	6	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 FN1 CALD1 SSC5D VCAN COL14A1	2.03e-05	193	128	6	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RANBP2 POU2F1 STRN BAZ2A MGA ZMYM4	2.03e-05	193	128	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNPO2 FN1 CALD1 COBLL1 MYO1B SVIL	2.03e-05	193	128	6	dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNPO2 FN1 CALD1 COBLL1 MYO1B SVIL	2.03e-05	193	128	6	2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 FN1 CALD1 SSC5D VCAN COL14A1	2.03e-05	193	128	6	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 MAP3K1 ITPR3 STRN PTPRJ SVIL	2.09e-05	194	128	6	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 FN1 CALD1 RGMA SSC5D SVIL	2.09e-05	194	128	6	d2bafd31bb8333f66b6c714944bceb2f1aa11740
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	CALD1 ANK3 MYOM3 PDLIM5 SVIL PDZD2	2.09e-05	194	128	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 FN1 CALD1 PDLIM5 VCAN ZFHX3	2.09e-05	194	128	6	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	TNIK ANK3 MYOM3 PDLIM5 SVIL FHIP1A	2.15e-05	195	128	6	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK MAP3K1 ITPR3 STRN SLC15A1 SVIL	2.15e-05	195	128	6	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SYNPO2 CALD1 NR4A1 SSC5D ZFHX3 AHNAK2	2.15e-05	195	128	6	dba2a87efd7e067c094c4b367feb4138cab62735
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 FN1 CALD1 RGMA SSC5D SVIL	2.15e-05	195	128	6	bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	ANK3 COBLL1 MYO1B KIAA1217 OSMR FHIP1A	2.15e-05	195	128	6	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	ASK428-Mesenchymal\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	SYNPO2 FN1 CALD1 MUC12 VCAN COL14A1	2.15e-05	195	128	6	2b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 FN1 CALD1 RGMA SSC5D SVIL	2.15e-05	195	128	6	8a04f0e92d10a368ccda5f566ae67ef51f1d34a9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK MAP3K1 ITPR3 STRN SLC15A1 SVIL	2.15e-05	195	128	6	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	ANK3 COBLL1 MYO1B KIAA1217 OSMR FHIP1A	2.15e-05	195	128	6	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 MUC16 CATSPER3 KIAA1217 MUC5AC FHIP1A	2.15e-05	195	128	6	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	ASK428-Mesenchymal-Fibroblast\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	SYNPO2 FN1 CALD1 MUC12 VCAN COL14A1	2.15e-05	195	128	6	c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNPO2 FN1 CALD1 COBLL1 MYO1B SVIL	2.21e-05	196	128	6	cb61757646653f89faba503cb5d99e5dd5197b4c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 TNFAIP8L3 CALD1 PDLIM5 SVIL COL14A1	2.21e-05	196	128	6	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	CUX2 CALD1 CHD9 PNISR FOXP4 SVIL	2.21e-05	196	128	6	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	CUX2 CALD1 CHD9 PNISR FOXP4 SVIL	2.21e-05	196	128	6	721650a08d260faf530dbd52d4e9275d27f3bac2
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	TPR MYO1B MAP3K1 PHC3 STRN ALMS1 ABCB9 HCFC1 MRTFA	1.23e-06	190	127	9	3373_DN
Drug	Hexestrol [84-16-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	TNIK JCAD NR4A1 PDLIM5 MAP3K1 SLC15A1 BAZ2A ITSN2 ALK	1.29e-06	191	127	9	6077_UP
Drug	Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	RELN COBLL1 BAP1 PHC3 ALMS1 ABCB9 HCFC1 AHNAK2 FCMR	1.53e-06	195	127	9	4817_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A	SZT2 COBLL1 U2AF2 STRN SLC15A1 BAZ2A VCAN ZFHX3 FCMR	1.53e-06	195	127	9	3732_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	COBLL1 U2AF2 HNRNPU PHC3 OSMR HCFC1 MRTFA FCMR	1.36e-05	194	127	8	2284_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A	TTF2 FN1 NR4A1 AHDC1 CIC MAP3K1 MRTFA PHLPP2	1.36e-05	194	127	8	6178_DN
Drug	PF-00875133-00 [351322-64-0]; Down 200; 10uM; PC3; HT_HG-U133A	JCAD CALD1 ANK3 AHDC1 PHC3 ZFHX3 OSMR FCMR	1.46e-05	196	127	8	5928_DN
Drug	AH6809; Down 200; 1uM; PC3; HT_HG-U133A	TNIK CALD1 ANK3 SZT2 U2AF2 VCAN AGFG1 OSMR	1.46e-05	196	127	8	7049_DN
Drug	Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A	FN1 COBLL1 NR4A1 BAZ2A VCAN COL14A1 HCFC1 MRTFA	1.52e-05	197	127	8	7401_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	GIT1 AHDC1 CIC EMSY BAP1 PHC3 SVIL AHNAK2	1.52e-05	197	127	8	3308_DN
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	MYO1B NR4A1 CIC BAP1 ALMS1 BAZ2A ALK HCFC1	1.52e-05	197	127	8	2766_UP
Drug	Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A	U2AF2 PDLIM5 ALMS1 ABCB9 BAZ2A ALK HCFC1 MRTFA	1.57e-05	198	127	8	1493_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A	TNIK GIT1 NR4A1 PNISR GRAMD4 ZFHX3 ALK HCFC1	1.57e-05	198	127	8	2128_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	FN1 CALD1 CIC ITPR3 ABCB9 ALK PDZD2 FOXP3	1.69e-05	200	127	8	5570_UP
Drug	rioprostil	MUC12 MUC3A MUC5AC ALK	2.94e-05	32	127	4	CID005311413
Drug	N-(all-trans-retinoyl)-DL-leucine	RELN C4A	3.09e-05	2	127	2	CID006439237
Drug	retinoylglycine	RELN C4A	3.09e-05	2	127	2	CID005379396
Drug	marimastat	TNFAIP8L3 FN1 NCSTN AAAS PTPRJ	3.93e-05	68	127	5	CID000119031
Drug	Chloroprene	TNIK TPR SYNPO2 FN1 CALD1 SZT2 CD300A EVI2B MYO1B NR4A1 PNISR EMSY SPAG5 HNRNPU FAM193A PHF20L1 TET1 ITSN2 MGA FCMR	5.66e-05	1348	127	20	ctd:D002737
Drug	guanidine hydrochloride	MUC12 SNAP91 VCAN MUC3A MUC5AC PLP1	8.69e-05	129	127	6	CID000005742
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	TPR ANK3 U2AF2 HNRNPU PHC3 AGFG1 OSMR	8.78e-05	187	127	7	4323_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A	DMXL2 CD300A KDM3B EMSY PDLIM5 PHC3 ALMS1	9.08e-05	188	127	7	1865_DN
Drug	2-aminothiophenol	C4A C4B	9.23e-05	3	127	2	ctd:C005464
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA	RANBP2 C2CD2 PDLIM5 ITSN2 AGFG1 HCFC1 ZMYM4	9.70e-05	190	127	7	1074_DN
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A	TNIK NR4A1 ITPR3 STRN ABCB9 VCAN PHLPP2	1.00e-04	191	127	7	4580_UP
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	DMXL2 MYO1B NR4A1 CIC EMSY ABCB9 HCFC1	1.10e-04	194	127	7	4411_DN
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	TPR FN1 ANK3 SZT2 HNRNPU VCAN HCFC1	1.14e-04	195	127	7	7058_DN
Drug	Riboflavine [83-88-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CIC PDLIM5 PHC3 BAZ2A MCTP2 MRTFA PHLPP2	1.14e-04	195	127	7	6822_UP
Drug	1zd2	FN1 PDLIM5 VCAN COL14A1	1.15e-04	45	127	4	CID004149241
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A	TNIK SZT2 COBLL1 PDLIM5 HNRNPU STRN OSMR	1.18e-04	196	127	7	1686_UP
Drug	Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A	SZT2 COBLL1 MYO1B NR4A1 BAZ2A ZFHX3 MRTFA	1.18e-04	196	127	7	3083_UP
Drug	5152487; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ANK3 COBLL1 U2AF2 PDLIM5 ALMS1 ABCB9 AGFG1	1.18e-04	196	127	7	896_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; PC3; HT_HG-U133A	FN1 COBLL1 EMSY PDLIM5 ABCB9 BAZ2A MRTFA	1.18e-04	196	127	7	6637_DN
Drug	Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	GIT1 COBLL1 GRAMD4 HNRNPU ALMS1 BAZ2A PPP6R2	1.18e-04	196	127	7	7485_DN
Drug	Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A	DMXL2 COBLL1 CIC VCAN MUC5AC MRTFA FCMR	1.22e-04	197	127	7	6830_UP
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A	DMXL2 PDLIM5 MAP3K1 ABCB9 SLC15A1 BAZ2A HCFC1	1.22e-04	197	127	7	2253_UP
Drug	Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A	ANK3 GIT1 CIC PHC3 BAZ2A PPP6R2 HCFC1	1.22e-04	197	127	7	7201_DN
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	NR4A1 STRN ABCB9 BAZ2A OSMR MRTFA AHNAK2	1.22e-04	197	127	7	1693_UP
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	PDLIM5 MAP3K1 PHC3 ABCB9 VCAN SYCP1 MUC5AC	1.22e-04	197	127	7	3196_UP
Drug	Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A	NPY5R NR4A1 MAP3K1 PHC3 COL14A1 ZFHX3 HCFC1	1.22e-04	197	127	7	6664_UP
Drug	Calciferol [50-14-6]; Up 200; 10uM; PC3; HT_HG-U133A	CALD1 CIC KMT2D MCTP2 ALK MRTFA PHLPP2	1.25e-04	198	127	7	6746_UP
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; PC3; HT_HG-U133A	GRAMD4 PDLIM5 AAAS VCAN HCFC1 MRTFA FCMR	1.25e-04	198	127	7	6725_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A	FN1 CIC PDLIM5 BAP1 ITPR3 BAZ2A SVIL	1.25e-04	198	127	7	7168_DN
Drug	Amoxicillin [26787-78-0]; Up 200; 11uM; HL60; HT_HG-U133A	GIT1 CD300A KDM3B NR4A1 PDLIM5 BAZ2A MCTP2	1.25e-04	198	127	7	1265_UP
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	COBLL1 NR4A1 ITPR3 ABCB9 COL14A1 MCTP2 PHLPP2	1.25e-04	198	127	7	4697_UP
Drug	Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	TNIK TTF2 FN1 PHC3 ABCB9 MCTP2 FCMR	1.25e-04	198	127	7	5742_DN
Drug	Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A	FN1 CALD1 PDLIM5 BAP1 TBC1D10B MRTFA AHNAK2	1.25e-04	198	127	7	6799_UP
Drug	Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A	GRAMD4 PDLIM5 ITSN2 COL14A1 ZFHX3 OSMR HCFC1	1.25e-04	198	127	7	5837_UP
Drug	Nifurtimox [23256-30-6]; Down 200; 14uM; PC3; HT_HG-U133A	CALD1 COBLL1 EMSY PDLIM5 ZFHX3 HCFC1 PDZD2	1.25e-04	198	127	7	6608_DN
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	NPY5R SZT2 ITPR3 PHC3 BAZ2A VCAN MRTFA	1.25e-04	198	127	7	4525_UP
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A	FN1 MYO1B GRAMD4 PHC3 PHF20L1 SVIL FCMR	1.25e-04	198	127	7	1299_DN
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A	DMXL2 FN1 SZT2 NR4A1 SLC15A1 MUC5AC FCMR	1.25e-04	198	127	7	3356_UP
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A	TNIK ANK3 ALMS1 OSMR PPP6R2 MRTFA FCMR	1.25e-04	198	127	7	4062_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	RELN CUX2 CALD1 EVI2B ALK PHLPP2 PDZD2	1.25e-04	198	127	7	3523_UP
Drug	PF-01378883-00 [351320-41-7]; Down 200; 10uM; PC3; HT_HG-U133A	TNIK FN1 CALD1 PHC3 ABCB9 OSMR FCMR	1.29e-04	199	127	7	6410_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	GIT1 CIC ABCB9 SYCP1 MUC5AC HCFC1 PHLPP2	1.29e-04	199	127	7	3206_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A	RELN FN1 U2AF2 VCAN PLP1 PHLPP2 FCMR	1.29e-04	199	127	7	4359_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	GIT1 COBLL1 MYO1B HNRNPU BAZ2A COL14A1 OSMR	1.29e-04	199	127	7	3543_DN
Drug	2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A	DMXL2 RELN CALD1 NR4A1 MAP3K1 COL14A1 AHNAK2	1.29e-04	199	127	7	3570_UP
Drug	Aminophylline [317-34-0]; Up 200; 9.6uM; PC3; HT_HG-U133A	GIT1 PHC3 ABCB9 BAZ2A ALK MRTFA FCMR	1.29e-04	199	127	7	6295_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; PC3; HT_HG-U133A	TNIK NPY5R FN1 MYO1B PDLIM5 PHC3 BAZ2A	1.29e-04	199	127	7	4247_UP
Drug	Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HG-U133A	TNIK CALD1 ANK3 GIT1 NR4A1 PDLIM5 ALMS1	1.33e-04	200	127	7	1899_UP
Drug	N da	RANBP2 NPY5R ADAR BSN	1.61e-04	49	127	4	CID000018409
Drug	Dynese	VCAN SPEN	1.84e-04	4	127	2	CID003086011
Disease	glucose measurement	TNIK CUX2 LRRC37A3 COBLL1 R3HDM2 RREB1 ITPR3 PTPRJ SNAP91 SP9 BSN	8.87e-07	380	128	11	EFO_0004468
Disease	Granuloma, Plasma Cell	RANBP2 ALK	1.87e-05	2	128	2	C0018199
Disease	creatinine measurement	CUX2 ICE2 CHD9 R3HDM2 RREB1 PDLIM5 TBC1D10B ALMS1 PTPRJ SVIL ZFHX3 TAF4 BSN UNC80 MRTFA	2.83e-05	995	128	15	EFO_0004518
Disease	esophagus squamous cell carcinoma (is_implicated_in)	MAP3K1 KMT2D COL14A1 SPEN	4.39e-05	45	128	4	DOID:3748 (is_implicated_in)
Disease	serum gamma-glutamyl transferase measurement	TNIK JCAD CUX2 CALD1 ICE2 COBLL1 CHD9 MYO1B RREB1 EMSY STRN SVIL TAF4 PPP6R2	4.48e-05	914	128	14	EFO_0004532
Disease	STRIATONIGRAL DEGENERATION, INFANTILE (disorder)	NUP62 ADAR	5.59e-05	3	128	2	C0795996
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	5.59e-05	3	128	2	DOID:9368 (is_marker_for)
Disease	Mammary Carcinoma, Human	FN1 LRRC37A2 ADAR EMSY MAP3K1 BAP1 KMT2D ITSN2 ALK FOXP3	1.02e-04	525	128	10	C4704874
Disease	Mammary Neoplasms, Human	FN1 LRRC37A2 ADAR EMSY MAP3K1 BAP1 KMT2D ITSN2 ALK FOXP3	1.02e-04	525	128	10	C1257931
Disease	Mammary Neoplasms	FN1 LRRC37A2 ADAR EMSY MAP3K1 BAP1 KMT2D ITSN2 ALK FOXP3	1.05e-04	527	128	10	C1458155
Disease	specific developmental disorder (implicated_via_orthology)	FOXP4 FOXP3	1.11e-04	4	128	2	DOID:0060038 (implicated_via_orthology)
Disease	Breast Carcinoma	FN1 LRRC37A2 ADAR EMSY MAP3K1 BAP1 KMT2D ITSN2 ALK FOXP3	1.24e-04	538	128	10	C0678222
Disease	reaction time measurement	TNIK CUX2 DCP2 LRRC37A2 MUC19 STRN KMT2D SNAP91 TET1 ITSN2 ZFHX3	1.44e-04	658	128	11	EFO_0008393
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	1.51e-04	24	128	3	DOID:12894 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	ZFHX3 MUC5AC	1.85e-04	5	128	2	DOID:3030 (is_marker_for)
Disease	Malignant neoplasm of breast	FN1 LRRC37A2 POU2F1 ADAR CIC EMSY MAP3K1 BAP1 FOXP4 KMT2D ITSN2 SPEN ALK FOXP3	2.43e-04	1074	128	14	C0006142
Disease	Human papillomavirus infectious disease (is_implicated_in)	ADAR FOXP3	2.77e-04	6	128	2	DOID:11166 (is_implicated_in)
Disease	Inflammatory Myofibroblastic Tumor	RANBP2 ALK	2.77e-04	6	128	2	C0334121
Disease	Prostatic Neoplasms	MAP3K1 BAP1 FOXP4 KMT2D AAAS BAZ2A ITSN2 ZFHX3 MGA SPEN	3.66e-04	616	128	10	C0033578
Disease	Malignant neoplasm of prostate	MAP3K1 BAP1 FOXP4 KMT2D AAAS BAZ2A ITSN2 ZFHX3 MGA SPEN	3.66e-04	616	128	10	C0376358
Disease	visual epilepsy (implicated_via_orthology)	NPY5R KDM3B PLP1	4.32e-04	34	128	3	DOID:11832 (implicated_via_orthology)
Disease	Autism Spectrum Disorders	RELN CIC TET1 UNC80	5.21e-04	85	128	4	C1510586
Disease	rheumatoid arthritis, Crohn's disease	EMSY C1orf141 BSN	6.02e-04	38	128	3	EFO_0000384, EFO_0000685
Disease	coronary artery disease	JCAD CUX2 FN1 R3HDM2 AHDC1 PDLIM5 MAP3K1 PTPRJ SLC15A1 KIAA1217 BSN MCTP2 ALK MRTFA	6.96e-04	1194	128	14	EFO_0001645
Disease	neuroimaging measurement	TNIK RELN ANK3 SZT2 RREB1 SHTN1 MAP3K1 STPG2 STRN SNAP91 PROSER3 VCAN SYCP1	7.79e-04	1069	128	13	EFO_0004346
Disease	venous thromboembolism, von Willebrand factor measurement	TTF2 FCHO2 PTPRJ	8.09e-04	42	128	3	EFO_0004286, EFO_0004629
Disease	2-ketocaprylate measurement	HEATR4 ALMS1	8.21e-04	10	128	2	EFO_0800110
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	8.21e-04	10	128	2	DOID:10140 (is_marker_for)
Disease	myocardial infarction	JCAD CUX2 FN1 AHDC1 PDLIM5 SLC15A1 PDZD2	8.63e-04	350	128	7	EFO_0000612
Disease	Microphthalmos	MFRP KMT2D	1.00e-03	11	128	2	C0026010
Disease	intracranial aneurysm (is_implicated_in)	KMT2D VCAN	1.20e-03	12	128	2	DOID:10941 (is_implicated_in)
Disease	cortical thickness, neuroimaging measurement	RREB1 SHTN1 STRN VCAN	1.37e-03	110	128	4	EFO_0004346, EFO_0004840
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 PTPRQ	1.41e-03	13	128	2	C1846647
Disease	neuroimaging measurement, brain volume measurement	TNIK SHTN1 MAP3K1 STRN PROSER3 VCAN	1.59e-03	286	128	6	EFO_0004346, EFO_0006930
Disease	Diffuse Large B-Cell Lymphoma	KMT2D SPEN ALK	1.77e-03	55	128	3	C0079744
Disease	hippocampal volume	TNIK STPG2 STRN KIAA1217 VCAN MCTP2	1.92e-03	297	128	6	EFO_0005035
Disease	cortical surface area measurement	TNIK RELN ANK3 FCHO2 RREB1 SHTN1 MAP3K1 STPG2 STRN VCAN AGFG1 ZFHX3 MCTP2 PDZD2	2.14e-03	1345	128	14	EFO_0010736
Disease	intracerebral hemorrhage	CUX2 FHIP1A	2.15e-03	16	128	2	EFO_0005669
Disease	T-Cell Lymphoma	KMT2D MGA	2.15e-03	16	128	2	C0079772
Disease	uridine diphosphate galactose measurement, uridine diphosphate glucose measurement	JCAD SVIL	2.43e-03	17	128	2	EFO_0010543, EFO_0010544
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC3A MUC5AC	2.74e-03	64	128	3	DOID:4947 (is_marker_for)
Disease	brain measurement, neuroimaging measurement	TNIK ANK3 RREB1 SHTN1 MAP3K1 STRN VCAN ZFHX3	2.81e-03	550	128	8	EFO_0004346, EFO_0004464
Disease	smoking cessation	ANK3 ITPR3 ALMS1 KIAA1217 ZFHX3 BSN	3.01e-03	325	128	6	EFO_0004319
Disease	emphysema pattern measurement	JCAD SVIL	3.04e-03	19	128	2	EFO_0005850
Disease	cortical surface area measurement, neuroimaging measurement	RREB1 SHTN1 STRN VCAN ZFHX3	3.17e-03	227	128	5	EFO_0004346, EFO_0010736
Disease	congenital heart disease (implicated_via_orthology)	CHD9 KMT2D HCFC1	3.39e-03	69	128	3	DOID:1682 (implicated_via_orthology)
Disease	carotid artery intima media thickness	JCAD CALD1 ICE2 VCAN SVIL MRTFA PDZD2	3.56e-03	450	128	7	EFO_0007117
Disease	blood urea nitrogen measurement	SYNPO2 CUX2 CHD9 R3HDM2 FCHO2 RREB1 SLC15A1	3.65e-03	452	128	7	EFO_0004741
Disease	haptoglobin measurement	ZFHX3 PHLPP2	3.71e-03	21	128	2	EFO_0004640
Disease	venous thromboembolism	TTF2 RELN ANK3 TMPRSS11F ITPR3 ABCB9 PTPRJ	4.02e-03	460	128	7	EFO_0004286
Disease	cervical squamous cell carcinoma (is_marker_for)	ADAR FOXP3	4.07e-03	22	128	2	DOID:3744 (is_marker_for)
Disease	Attention Deficit Disorder	GIT1 CIC	4.07e-03	22	128	2	C0041671
Disease	Minimal Brain Dysfunction	GIT1 CIC	4.07e-03	22	128	2	C1321905

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPDGSKILATTPSAV	AAAS	296	Q9NRG9
FSAGKPTSIPTSSAL	C1orf141	351	Q5JVX7
SPVDTTSVGFCPTFK	CATSPER3	16	Q86XQ3
VPSAKAVTADGFPTV	VCAN	2471	P13611
SPASGIPVKVSATVS	C4B	396	P0C0L5
STGLEATFPKTTPLA	PRKAG3	86	Q9UGI9
AIVFGGTTTPVPKSA	ADGRG4	816	Q8IZF6
GAISSIPKTTFSPFL	ADGRG4	1686	Q8IZF6
QVSPSLTSFKSASGP	ADGRG4	1766	Q8IZF6
TSPKASPVTSPAAAF	BAZ2A	491	Q9UIF9
AVSTPSTQKPLVFGA	GRAMD4	536	Q6IC98
SFPSGIIKVFTSNPT	FCHO2	576	Q0JRZ9
VTSPSSSFGEKPIVI	ALMS1	1471	Q8TCU4
IPLSIKTSSGAGSPA	BAP1	461	Q92560
KTSSGAGSPAVAVPT	BAP1	466	Q92560
IRKGVSASAVPFTPS	GIT1	556	Q9Y2X7
FATASAAVPVSTSKP	SNAP91	331	O60641
IPVAFPSGDASSLSK	DMXL2	546	Q8TDJ6
NGFSSTGSTPAKPTV	DCP2	251	Q8IU60
ATFPSRGAKASPVAV	AHDC1	886	Q5TGY3
KTSVAPLSIANGTTP	CUX2	671	O14529
SSSGPSPFALAVVKR	COBLL1	981	Q53SF7
SFPKTATTTPGFVDT	FAM193A	701	P78312
RPPVTKASSFSGISI	R3HDM2	341	Q9Y2K5
PATSIPTPASFKFGT	RANBP2	1511	P49792
TSVPAPASFKFGTSE	RANBP2	1576	P49792
GEGPSATFTKVTTPD	OSMR	721	Q99650
KSAFTRTVSPGSVSP	ITSN2	876	Q9NZM3
PVDPTTKGRVASFSI	ITPR3	1821	Q14573
LAVSLTKPSPASGFS	NCSTN	121	Q92542
LDTPVTSTKARSGAP	NR4A1	246	P22736
TPTITTSQAAGTPKG	MFRP	116	Q9BY79
ASQAGKAPVTVTSLP	HCFC1	506	P51610
GVPVSVSPAVSKTAA	MUC16	646	Q8WXI7
SPRFKTGLPSATTTV	MUC16	971	Q8WXI7
KPTSAESGLLTPVSA	MUC16	2851	Q8WXI7
TSTPGTPTVYLGASK	MUC16	13761	Q8WXI7
PTFSAPVGESATAKF	FIGNL1	201	Q6PIW4
STGPSPVFDIKAVSI	PTPRJ	116	Q12913
SVLKPFSKGAPSTSS	LRRC37A3	1246	O60309
TSVPSSLSTAGIFPK	MCTP2	76	Q6DN12
VARGPVAPSKVATTS	MAFK	121	O60675
PAVFVTSSVSSPVKF	KIAA0895	171	Q8NCT3
SVLKPFSKGAPSTSS	LRRC37A2	1246	A6NM11
PNPKIASSVTAGVAS	NEDD1	551	Q8NHV4
LTPPTTATGVFSLKA	FOXP3	131	Q9BZS1
LISTKNTPVSPGSTF	MGA	636	Q8IWI9
ASVAFPKSLVASPST	MGA	1671	Q8IWI9
TSAFSSVKPSEAVPR	JCAD	1006	Q9P266
GLTGPTTVPATKASL	BSN	2926	Q9UPA5
IKPSVAGSVTTGPSV	MUC19	2976	Q7Z5P9
GVVPATTVAPGSSKT	MUC19	6411	Q7Z5P9
IKSAAVPSGTTVAPG	MUC19	7286	Q7Z5P9
GSFKTAVSSTPPITS	MUC3A	1751	Q02505
PVAKSGASPFLSVSS	PDZD2	2351	O15018
TSTVKNSPRSTPGFI	EVI2B	171	P34910
KSSGPTSLFAVTVAP	HNRNPU	186	Q00839
PPVFSTSSAGVKSKA	KDM3B	1316	Q7LBC6
AATATSFAAPPKVSP	FOXP4	256	Q8IVH2
PVPGSSSFSKVTVSA	FOXP4	386	Q8IVH2
APGTATSVKKTFSTP	MUC5AC	1526	P98088
TTPAPGTATSVKKTF	MUC5AC	1896	P98088
GTATSVKKTFSTPSP	MUC5AC	1901	P98088
TSLTAAAAFKPVGST	PDLIM5	341	Q96HC4
STGPSLFASIATAPT	NUP62	216	P37198
PAVASVSASVIKSPS	PHC3	641	Q8NDX5
SSGGTSSSPIKAIFP	POU2F1	441	P14859
SGSVSQPSVFFPTKG	RELN	2801	P78509
SAGTGPKSNISVFTP	PTPRQ	421	Q9UMZ3
AAKPALTPSFGSSFT	POM121B	566	A6NF01
TPLKATSGPAIASTA	C6orf132	681	Q5T0Z8
SLVNFPKSIPVSGTS	CHD9	2396	Q3L8U1
STPFTGPFISVVLSK	FHIP1A	846	Q05DH4
FGVTTTKVSKSPSPA	ICE2	406	Q659A1
KAGTTTVAPSAPDIS	ICE2	436	Q659A1
VGRASPLSSDSPVKT	C2CD2	431	Q9Y426
AVGAQTFPSVSAPSK	ADAR	651	P55265
PKATGVFTTLQPGSS	FN1	1076	P02751
PVQEFTVPGSKSTAT	FN1	1581	P02751
EGVSVSAPGKTLPSS	COL14A1	816	Q05707
PVSFKFLGSSSPLTG	HEATR4	116	Q86WZ0
ITVPGPAKSGFTSLS	ANK3	1511	Q12955
VNGSISPLKYPSSST	ANK3	1716	Q12955
ASTSLKPPTADLFTG	MAN2B1	241	O00754
SSVGLAKGTLPSIFT	ITIH6	1061	Q6UXX5
QTSVVVKSIPASSPG	EMSY	881	Q7Z589
GGSSVPKLTSPVTSI	EMSY	1121	Q7Z589
TFSGFVTTKVPFPLT	EMC3	131	Q9P0I2
SSPGSPVTAVTDDFK	SLC15A1	441	P46059
SPASGIPVKVSATVS	C4A	396	P0C0L4
AITTALSKAGPAIPT	PPP6R2	901	O75170
VGSTPASLAVSAKDP	OTP	66	Q5XKR4
VSSPSPATDGKVFSI	PHF20L1	431	A8MW92
VSTTLPTSFPGASIA	MUC17	3881	Q685J3
IFKIASATTAPSIPS	MAP3K1	1461	Q13233
AGKTAATVTSALQPP	TAF4	706	O00268
LETKSSAGRASTFPP	SZT2	2411	Q5T011
VEALTFPPSSGKSFI	STRN	396	O43815
VVLGPTSGSPKTVAT	THAP8	131	Q8NA92
STPVPLLGSDKSAFT	SPAG5	936	Q96R06
GKLIPFSPAVNTSVS	SVIL	866	O95425
PVASTATSTKIFPLT	RESF1	821	Q9HCM1
SQLSSSSKFIPGVPT	NPY5R	321	Q15761
ETVPKASFGFSGISP	KIAA1217	1261	Q5T5P2
TSSKVTFQPPSSIGC	SHTN1	551	A0MZ66
ATTVKASPPAFQVGS	PROSER3	361	Q2NL68
STKPGTSSAPFTINA	WDR45	176	Q9Y484
LPGELATKPSASVTA	SSC5D	596	A1L4H1
NTPVLPGSAATATSK	RGMA	201	Q96B86
KGVAPPTLITDSTGT	MRTFA	651	Q969V6
SPLTTLPESSAFAKG	SP9	31	P0CG40
ALGGSTSPTSVIKFL	TET1	316	Q8NFU7
SFSLSPGKVTALVGP	ABCB9	526	Q9NP78
SATVTSATFPAPIKS	ALK	531	Q9UM73
PSFGVSAPGKSIEAS	AHNAK2	1336	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	1501	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	1666	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	1831	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	2161	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	2491	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	2821	Q8IVF2
PSFGVSAPGKSIEVS	AHNAK2	2986	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	3811	Q8IVF2
PSFGVSAPGKSIEAS	AHNAK2	4306	Q8IVF2
VFSSPTAAGTPNKET	CALD1	721	Q05682
TTGKAPVGSVVSVPS	AGFG1	351	P52594
ITAAKTSTITTAFPP	CD300A	136	Q9UGN4
TAFPPVSSTTLFAVG	CD300A	146	Q9UGN4
IASKPFPTSGRAEAS	CIC	686	Q96RK0
VAKAPSLTFASPASP	CIPC	251	Q9C0C6
KSVSVSSFQGSPATP	LINC00477	11	Q96M19
YGVSSTKTSAPSPKV	C10orf82	156	Q8WW14
GSSTKASFTPFVDPR	TNIK	966	Q9UKE5
PVTAAGPDVFSSKSL	TNFAIP8L3	101	Q5GJ75
PTPFKSTGDIAGTVV	TJP2	456	Q9UDY2
IPFVLTVGSGSKDSP	UNC80	2716	Q8N2C7
LPPKTSVFVTGFGSI	TMPRSS11F	321	Q6ZWK6
AFPTSNPSKGTVVSS	SYNPO2	791	Q9UMS6
PAASSVGLPSRTKTA	SPEN	3326	Q96T58
GPVGFASTTTIKDAP	PHLPP2	1051	Q6ZVD8
GSVPKAATTATPAAT	RREB1	1106	Q92766
FGTVSATPSSSLPKR	TPR	1816	P12270
KAPSSLTTPGSTLKF	SYCP1	931	Q15431
TFTIASSIEKAVPGP	STPG2	51	Q8N412
VAGDKPRTFLPSTTA	FCMR	196	O60667
PRTFLPSTTASKISA	FCMR	201	O60667
LAPKPGTTVASGVTA	TBC1D10B	171	Q4KMP7
SVGAKNATLVSPPST	U2AF2	336	P26368
PVTGTTFKSPLEVFA	WDR93	291	Q6P2C0
EAASSGKVTRSPSPV	PNISR	301	Q8TF01
KISAVFSVSGSPLAP	ZMYM4	296	Q5VZL5
FVSSKPGSPLLFDST	TTF2	361	Q9UNY4
LTDSPATSKRISFPG	ZFHX3	1186	Q15911
KGEAPTATAATISAP	ZFHX3	3261	Q15911
STSADGFLKPPAGSV	KMT2D	2136	O14686
SVFVGEPKTSPITSA	MUC12	246	Q9UKN1
SPAPSGTTSAFVKLS	MUC12	431	Q9UKN1
RPPTAGSQFKASVAT	MYO1B	566	O43795
TFGPSVEFTSVLKPV	MYOM3	266	Q5VTT5
SIAFPSKTSASIGSL	PLP1	186	P60201